Alcresta is a leading medical nutrition company leveraging its proprietary platform to develop and commercialize a broad range of innovative, point-of-care, enzyme-based products designed to improve health and manage disease through better nutrition.

Read more

Alcresta Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Develop Point-of-Care Nutritional Products

Read More >

Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products

Read More >